Dominari Holdings

Dominari Holdings is a diversified platform operating in biotechnology drug development and financial services. In biotech, it leverages patented technology from leading universities to develop an innovative therapeutic drug platform through partnerships with institutions such as The University of Texas at Austin and Wake Forest University, pursuing a pipeline that addresses oncology indications including pancreatic cancer, AML, and ALL, with ongoing efforts to expand treatment options for unmet medical needs. In financial services, the company operates through subsidiaries engaged in wealth management, investment banking, securities sales and trading, and asset management, structured into two reportable segments: Dominari Financial, a broker-dealer business centered on underwriting and transactional services, and Legacy AIkido, which oversees investment holdings via Aikido Labs, generating the majority of revenue from the Dominari Financial segment.